<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32121118</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules25051086</ELocationID><Abstract><AbstractText>Zinc (II) ions (hereafter simplified as zinc) are important for the structural and functional activity of many proteins. For Cu, Zn superoxide dismutase (Sod1), zinc stabilizes the native structure of each Sod1 monomer, promotes homo-dimerization and plays an important role in activity by "softening" the active site so that copper cycling between Cu(I) and Cu(II) can rapidly occur. Previously, we have reported that binding of Sod1 by its copper chaperone (Ccs) stabilizes a conformation of Sod1 that promotes site-specific high-affinity zinc binding. While there are a multitude of Sod1 mutations linked to the familial form of amyotrophic lateral sclerosis (fALS), characterizations by multiple research groups have been unable to realize strong commonalities among mutants. Here, we examine a set of fALS-linked Sod1 mutations that have been well-characterized and are known to possess variation in their biophysical characteristics. The zinc affinities of these mutants are evaluated here for the first time and then compared with the previously established value for wild-type Sod1 zinc affinity. Ccs does not have the same ability to promote zinc binding to these mutants as it does for the wild-type version of Sod1. Our data provides a deeper look into how (non)productive Sod1 maturation by Ccs may link a diverse set of fALS-Sod1 mutations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>Stefanie D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, the University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX 75080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullrich</LastName><ForeName>Morgan S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, the University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX 75080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Jenifer S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-0938-2602</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, the University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX 75080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behnia</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, the University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX 75080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meloni</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4976-1401</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, the University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX 75080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Duane D</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0003-1045-0323</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, the University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX 75080, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM120252</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM128704</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01GM120252</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C114678">CCS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>J41CSQ7QDS</RegistryNumber><NameOfSubstance UI="D015032">Zinc</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015032" MajorTopicYN="N">Zinc</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Ccs</Keyword><Keyword MajorTopicYN="N">Sod1</Keyword><Keyword MajorTopicYN="N">enzyme maturation</Keyword><Keyword MajorTopicYN="N">metallo-chaperone</Keyword><Keyword MajorTopicYN="N">zinc</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32121118</ArticleId><ArticleId IdType="pmc">PMC7179120</ArticleId><ArticleId IdType="doi">10.3390/molecules25051086</ArticleId><ArticleId IdType="pii">molecules25051086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hambidge M. Human zinc deficiency. J. Nutr. 2000;130:1344S&#x2013;1349S. doi: 10.1093/jn/130.5.1344S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/130.5.1344S</ArticleId><ArticleId IdType="pubmed">10801941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocha&#x144;czyk T., Drozd A., Kr&#x119;&#x17c;el A. Relationship between the architecture of zinc coordination and zinc binding affinity in proteins--insights into zinc regulation. Metallomics. 2015;7:244&#x2013;257. doi: 10.1039/C4MT00094C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4MT00094C</ArticleId><ArticleId IdType="pubmed">25255078</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J. Biol. Chem. 2006;281:24085&#x2013;24089. doi: 10.1074/jbc.R600011200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R600011200</ArticleId><ArticleId IdType="pubmed">16793761</ArticleId></ArticleIdList></Reference><Reference><Citation>Eide D.J. Zinc transporters and the cellular trafficking of zinc. Biochim. Biophys. Acta. 2006;1763:711&#x2013;722. doi: 10.1016/j.bbamcr.2006.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2006.03.005</ArticleId><ArticleId IdType="pubmed">16675045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekler I., Sensi S.L., Hershfinkel M., Silverman W.F. Mechanism and regulation of cellular zinc transport. Mol. Med. 2007;13:337&#x2013;343. doi: 10.2119/2007-00037.Sekler.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/2007-00037.Sekler</ArticleId><ArticleId IdType="pmc">PMC1952664</ArticleId><ArticleId IdType="pubmed">17622322</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelmenschikov V., Siegbahn P.E. Copper-zinc superoxide dismutase: Theoretical insights into the catalytic mechanism. Inorg. Chem. 2005;44:3311&#x2013;3320. doi: 10.1021/ic050018g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ic050018g</ArticleId><ArticleId IdType="pubmed">15847441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons T.J., Gralla E.B., Valentine J.S. Biological chemistry of copper-zinc superoxide dismutase and its link to amyotrophic lateral sclerosis. Met. Ions Biol. Syst. 1999;36:125&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">10093924</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetherolf M.M., Boyd S.D., Winkler D.D., Winge D.R. Oxygen-dependent activation of Cu,Zn-superoxide dismutase-1. Metallomics. 2017;9:1047&#x2013;1059. doi: 10.1039/C6MT00298F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MT00298F</ArticleId><ArticleId IdType="pubmed">28686251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturtz L.A., Diekert K., Jensen L.T., Lill R., Culotta V.C. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem. 2001;276:38084&#x2013;38089.</Citation><ArticleIdList><ArticleId IdType="pubmed">11500508</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetherolf M.M., Boyd S.D., Taylor A.B., Kim H.J., Wohlschlegel J.A., Blackburn N.J., Hart P.J., Winkler D.D. Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site. J. Biol. Chem. 2017;292:12025&#x2013;12040. doi: 10.1074/jbc.M117.775981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.775981</ArticleId><ArticleId IdType="pmc">PMC5519355</ArticleId><ArticleId IdType="pubmed">28533431</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Cantini F., Kozyreva T., Massagni C., Palumaa P., Rubino J.T., Zovo K. Human superoxide dismutase 1 (hSOD1) maturation through interaction with human copper chaperone for SOD1 (hCCS) Proc. Natl. Acad. Sci. USA. 2012;109:13555&#x2013;13560. doi: 10.1073/pnas.1207493109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207493109</ArticleId><ArticleId IdType="pmc">PMC3427097</ArticleId><ArticleId IdType="pubmed">22869735</ArticleId></ArticleIdList></Reference><Reference><Citation>Culotta V.C., Klomp L.W.J., Strain J., Casareno R.L.B., Krems B., Gitlin J.D. The Copper Chaperone for Superoxide Dismutase. J. Biol. Chem. 1997;272:23469&#x2013;23472. doi: 10.1074/jbc.272.38.23469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.38.23469</ArticleId><ArticleId IdType="pubmed">9295278</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd S.D., Liu L., Bulla L., Winkler D.D. Quantifying the Interaction between Copper-Zinc Superoxide Dismutase (Sod1) and its Copper Chaperone (Ccs1) J. Proteom. Bioinform. 2018;11:473. doi: 10.4172/jpb.1000473.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/jpb.1000473</ArticleId><ArticleId IdType="pmc">PMC6018003</ArticleId><ArticleId IdType="pubmed">29950795</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnesano F., Banci L., Bertini I., Martinelli M., Furukawa Y., O&#x2019;Halloran T.V. The Unusually Stable Quaternary Structure of Human Cu,Zn-Superoxide Dismutase 1 Is Controlled by Both Metal Occupancy and Disulfide Status. J. Biol. Chem. 2004;279:47998&#x2013;48003. doi: 10.1074/jbc.M406021200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M406021200</ArticleId><ArticleId IdType="pubmed">15326189</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O&#x2019;Halloran T.V. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J. Biol. Chem. 2005;280:17266&#x2013;17274. doi: 10.1074/jbc.M500482200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500482200</ArticleId><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd S.D., Calvo J.S., Liu L., Ullrich M.S., Skopp A., Meloni G., Winkler D.D. The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation. J. Biol. Chem. 2019;294:1956&#x2013;1966. doi: 10.1074/jbc.RA118.005283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005283</ArticleId><ArticleId IdType="pmc">PMC6369272</ArticleId><ArticleId IdType="pubmed">30530491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling A.C., Schulz J.B., Brown R.H., Jr., Beal M.F. Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis. J. Neurochem. 1993;61:2322&#x2013;2325. doi: 10.1111/j.1471-4159.1993.tb07478.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb07478.x</ArticleId><ArticleId IdType="pubmed">8245985</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., Wilcox H.M., Flood D.G., Beal M.F., Brown R.H., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 1996;13:43&#x2013;47. doi: 10.1038/ng0596-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0596-43</ArticleId><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., Dykes-Hoberg M., Culotta V.C., Price D.L., Wong P.C., Rothstein J.D. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 2001;8:933&#x2013;941. doi: 10.1006/nbdi.2001.0443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0443</ArticleId><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourassa M.W., Brown H.H., Borchelt D.R., Vogt S., Miller L.M. Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS. Front. Aging Neurosci. 2014;6:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4059277</ArticleId><ArticleId IdType="pubmed">24982630</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B.F., Valentine J.S. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem. Sci. 2007;32:78&#x2013;85. doi: 10.1016/j.tibs.2006.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2006.12.005</ArticleId><ArticleId IdType="pubmed">17208444</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuoka M., Tokuda E., Nakagome K., Wu Z., Nagano I., Furukawa Y. An essential role of N-terminal domain of copper chaperone in the enzymatic activation of Cu/Zn-superoxide dismutase. J. Inorg. Biochem. 2017;175:208&#x2013;216. doi: 10.1016/j.jinorgbio.2017.07.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinorgbio.2017.07.036</ArticleId><ArticleId IdType="pubmed">28780408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugaya K., Nakano I. Prognostic role of &#x201c;prion-like propagation&#x201d; in SOD1-linked familial ALS: An alternative view. Front. Cell. Neurosci. 2014;8:359. doi: 10.3389/fncel.2014.00359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00359</ArticleId><ArticleId IdType="pmc">PMC4215625</ArticleId><ArticleId IdType="pubmed">25400549</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005;74:563&#x2013;593. doi: 10.1146/annurev.biochem.72.121801.161647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M., Yang Y., Deng H.X., Hung W.Y., Siddique N., Dellefave L., Gellera C., Andersen P.M., Siddique T. Age and founder effect of SOD1 A4V mutation causing ALS. Neurology. 2009;72:1634&#x2013;1639. doi: 10.1212/01.wnl.0000343509.76828.2a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000343509.76828.2a</ArticleId><ArticleId IdType="pmc">PMC2683645</ArticleId><ArticleId IdType="pubmed">19176896</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharaman S.V., Prudencio M., Karch C., Holloway S.P., Borchelt D.R., Hart P.J. Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis. Exp. Biol. Med. 2009;234:1140&#x2013;1154. doi: 10.3181/0903-MR-104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-MR-104</ArticleId><ArticleId IdType="pmc">PMC2850267</ArticleId><ArticleId IdType="pubmed">19596823</ArticleId></ArticleIdList></Reference><Reference><Citation>Galaleldeen A., Strange R.W., Whitson L.J., Antonyuk S.V., Narayana N., Taylor A.B., Schuermann J.P., Holloway S.P., Hasnain S.S., Hart P.J. Structural and biophysical properties of metal-free pathogenic SOD1 mutants A4V and G93A. Arch. Biochem. Biophys. 2009;492:40&#x2013;47. doi: 10.1016/j.abb.2009.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2009.09.020</ArticleId><ArticleId IdType="pmc">PMC2787720</ArticleId><ArticleId IdType="pubmed">19800308</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz M.E., McKenna-Yasek D., Chen C., Hedley-Whyte E.T., Brown R.H. Limited Corticospinal Tract Involvement in Amyotrophic Lateral Sclerosis Subjects with the A4V Mutation in the Copper/Zinc Superoxide Dismutase Gene. Ann. Neurol. 1998;43:703&#x2013;710. doi: 10.1002/ana.410430604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430604</ArticleId><ArticleId IdType="pubmed">9629839</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Nagano S., Duce J., Kiaei M., Li Q.-X., Tucker S., Tiwari A., Brown R., Jr., Beal M.H., Hayward L.J., et al. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2007;42:1534&#x2013;1542. doi: 10.1016/j.freeradbiomed.2007.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2007.02.004</ArticleId><ArticleId IdType="pubmed">17448900</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso R.M., Thayer M.M., DiDonato M., Lo T.P., Bruns C.K., Getzoff E.D., Tainer J.A. Insights into Lou Gehrig&#x2019;s disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. J. Mol. Biol. 2002;324:247&#x2013;256. doi: 10.1016/S0022-2836(02)01090-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(02)01090-2</ArticleId><ArticleId IdType="pubmed">12441104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E. Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 1994;331:1721&#x2013;1722. doi: 10.1056/NEJM199412223312516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199412223312516</ArticleId><ArticleId IdType="pubmed">7832899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lelie H.L., Liba A., Bourassa M.W., Chattopadhyay M., Chan P.K., Gralla E.B., Miller L.M., Borchelt D.R., Valentine J.S., Whitelegge J.P. Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice. J. Biol. Chem. 2011;286:2795&#x2013;2806. doi: 10.1074/jbc.M110.186999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.186999</ArticleId><ArticleId IdType="pmc">PMC3024775</ArticleId><ArticleId IdType="pubmed">21068388</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M., Puttaparthi K., Kawamata H., Rajendran B., Boyer P.J., Manfredi G., Elliott J.L. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proc. Natl. Acad. Sci. USA. 2007;104:6072&#x2013;6077. doi: 10.1073/pnas.0610923104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0610923104</ArticleId><ArticleId IdType="pmc">PMC1851618</ArticleId><ArticleId IdType="pubmed">17389365</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2001;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Antonyuk S., Seetharaman S.V., Whitson L.J., Taylor A.B., Holloway S.P., Strange R.W., Doucette P.A., Valentine J.S., Tiwari A., et al. Structures of the G85R variant of SOD1 in Familial Amyotrophic Lateral Sclerosis. JBC. 2008;283:16169&#x2013;16177. doi: 10.1074/jbc.M801522200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M801522200</ArticleId><ArticleId IdType="pmc">PMC2414278</ArticleId><ArticleId IdType="pubmed">18378676</ArticleId></ArticleIdList></Reference><Reference><Citation>Seetharaman S.V., Winkler D.D., Taylor A.B., Cao X., Whitson L.J., Doucette P.A., Valentine J.S., Schirf V., Demeler B., Carroll M.C., et al. Disrupted zinc-binding sites in structures of pathogenic SOD1 variants D124V and H80R. Biochemistry. 2010;49:5714&#x2013;5725. doi: 10.1021/bi100314n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi100314n</ArticleId><ArticleId IdType="pmc">PMC3037816</ArticleId><ArticleId IdType="pubmed">20515040</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange R.W., Antonyuk S.V., Hough M.A., Doucette P.A., Valentine J.S., Hasnain S.S. Variable metallation of human superoxide dismutase: Atomic resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. J. Mol. Biol. 2006;356:1152&#x2013;1162. doi: 10.1016/j.jmb.2005.11.081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.11.081</ArticleId><ArticleId IdType="pubmed">16406071</ArticleId></ArticleIdList></Reference><Reference><Citation>Skopp A., Boyd S.D., Ullrich M.S., Liu L., Winkler D.D. Copper-zinc superoxide dismutase (Sod1) activation terminates interaction between its copper chaperone (Ccs) and the cytosolic metal-binding domain of the copper importer Ctr1. Biometals. 2019;32:695&#x2013;705. doi: 10.1007/s10534-019-00206-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-019-00206-3</ArticleId><ArticleId IdType="pmc">PMC6647829</ArticleId><ArticleId IdType="pubmed">31292775</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler D.D., Luger K., Hieb A.R. Quantifying chromatin-associated interactions: The HI-FI system. Methods Enzym. 2012;512:243&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">22910210</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Torres A.S., O&#x2019;Halloran T.V. Oxygen-induced maturation of SOD1: A key role for disulfide formation by the copper chaperone CCS. EMBO J. 2004;23:2872&#x2013;2881. doi: 10.1038/sj.emboj.7600276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600276</ArticleId><ArticleId IdType="pmc">PMC1150991</ArticleId><ArticleId IdType="pubmed">15215895</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang Y.M., Stathopulos P.B., Dimmick K., Yang H., Badiei H.R., Tong M.S., Rumfeldt J.A., Chen P., Karanassios V., Meiering E.M. Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis. J. Biol. Chem. 2010;285:41701&#x2013;41711. doi: 10.1074/jbc.M110.113696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.113696</ArticleId><ArticleId IdType="pmc">PMC3009897</ArticleId><ArticleId IdType="pubmed">20974846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Y., Chattopadhyay M., Whitelegge J., Valentine J.S. SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status. Curr. Top. Med. Chem. 2012;12:2560&#x2013;2572. doi: 10.2174/1568026611212220010.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026611212220010</ArticleId><ArticleId IdType="pubmed">23339308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb A.L., Wernimont A.K., Pufahl R.A., O&#x2019;Halloran T.V., Rosenzweig A.C. Crystal structure of the second domain of the human copper chaperone for superoxide dismutase. Biochemistry. 2000;39:1589&#x2013;1595. doi: 10.1021/bi992822i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi992822i</ArticleId><ArticleId IdType="pubmed">10677207</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Cantini F., Kozyreva T., Rubino J.T. Mechanistic aspects of hSOD1 maturation from the solution structure of Cu(I) -loaded hCCS domain 1 and analysis of disulfide-free hSOD1 mutants. Chembiochem. 2013;14:1839&#x2013;1844. doi: 10.1002/cbic.201300042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201300042</ArticleId><ArticleId IdType="pubmed">23625804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidlin T., Kennedy B.K., Daggett V. Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V. Biophys. J. 2009;97:1709&#x2013;1718. doi: 10.1016/j.bpj.2009.06.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2009.06.043</ArticleId><ArticleId IdType="pmc">PMC2749781</ArticleId><ArticleId IdType="pubmed">19751676</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Boca M., Girotto S., Martinelli M., Valentine J.S., Vieru M. SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization. PLoS ONE. 2008;3 doi: 10.1371/journal.pone.0001677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001677</ArticleId><ArticleId IdType="pmc">PMC2250751</ArticleId><ArticleId IdType="pubmed">18301754</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchinat E., Barbieri L., Banci L. A molecular chaperone activity of CCS restores the maturation of SOD1 fALS mutants. Sci. Rep. 2017;7:17433. doi: 10.1038/s41598-017-17815-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17815-y</ArticleId><ArticleId IdType="pmc">PMC5727297</ArticleId><ArticleId IdType="pubmed">29234142</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O&#x2019;Halloran T.V. Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyotrophic lateral sclerosis. Antioxid. Redox Signal. 2006;8:847&#x2013;867. doi: 10.1089/ars.2006.8.847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2006.8.847</ArticleId><ArticleId IdType="pmc">PMC1633719</ArticleId><ArticleId IdType="pubmed">16771675</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman H.J., Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J. Biol. Chem. 1973;248:2645&#x2013;2649.</Citation><ArticleIdList><ArticleId IdType="pubmed">4697386</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman H.J., Evans H.J., Hill R.L., Fridovich I. Histidine at the active site of superoxide dismutase. Biochemistry. 1973;12:823&#x2013;827. doi: 10.1021/bi00729a006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00729a006</ArticleId><ArticleId IdType="pubmed">4346922</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartz J.W., Deutsch H.F. Preparation and physicochemical properties of human erythrocuprein. J. Biol. Chem. 1969;244:4565&#x2013;4572.</Citation><ArticleIdList><ArticleId IdType="pubmed">4309143</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler D.D., Schuermann J.P., Cao X., Holloway S.P., Borchelt D.R., Carroll M.C., Proescher J.B., Culotta V.C., Hart P.J. Structural and biophysical properties of the pathogenic SOD1 variant H46R/H48Q. Biochemistry. 2009;48:3436&#x2013;3447. doi: 10.1021/bi8021735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi8021735</ArticleId><ArticleId IdType="pmc">PMC2757159</ArticleId><ArticleId IdType="pubmed">19227972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Waggoner D., Subramaniam J.R., Tessarollo L., Bartnikas T.B., Culotta V.C., Price D.L., Rothstein J., Gitlin J.D. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA. 2000;97:2886&#x2013;2891. doi: 10.1073/pnas.040461197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.040461197</ArticleId><ArticleId IdType="pmc">PMC16025</ArticleId><ArticleId IdType="pubmed">10694572</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez J.A., Shaw B.F., Durazo A., Sohn S.H., Doucette P.A., Nersissian A.M., Faull K.F., Eggers D.K., Tiwari A., Hayward L.J., et al. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 2005;102:10516&#x2013;10521. doi: 10.1073/pnas.0502515102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0502515102</ArticleId><ArticleId IdType="pmc">PMC1175580</ArticleId><ArticleId IdType="pubmed">16020530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova M.I., Sievers S.A., Guenther E.L., Johnson L.M., Winkler D.D., Galaleldeen A., Sawaya M.R., Hart P.J., Eisenberg D.S. Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc. Natl. Acad. Sci. USA. 2014;111:197&#x2013;201. doi: 10.1073/pnas.1320786110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320786110</ArticleId><ArticleId IdType="pmc">PMC3890817</ArticleId><ArticleId IdType="pubmed">24344300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>